$LLY: Eli Lilly and Boehringer Ingelheim’s Tradjenta successful in CV …

Date: Thursday, February 14th, 2019

Stock(s) mentioned:

Source: Seeking Alpha (https://seekingalpha.com)

Summary: Eli Lilly (NYSE:LLY) and alliance partner Boehringer Ingelheim announce that the CAROLINA study assessing cardiovascular (CV) outcomes in type 2 diabetics …

Full article address: https://seekingalpha.com/news/3433257-eli-lilly-boehringer-ingelheims-tradjenta-successful-cv-outcome-study

Related News:

$LLY $PFE: Better Buy: Eli Lilly vs. Pfizer

$MRK $PFE $BAYRY $JNJ $LLY: Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs

$PFE $LLY $SNY $REGN: Pfizer’s Eczema Candidate Meets All Goals in Phase III Study

$LLY: Data Presentations at ASCO 2019 Highlight Lilly’s Targeted …

$LLY: 3 Stocks With Big News Coming at ASCO 2019

$AZN $LLY $MDT: 3 Top Diabetes Stocks to Watch in May

$LLY: Lilly to Participate in Bank of America Merrill Lynch Health Care …

$BAYRY $LLY $MRK $AMGN: Lilly’s Cyramza Gets FDA Nod for Second-Line Liver Cancer

$JAZZ $LLY: Pfenex: The First US Forteo Biosim And A Host Of Other Biosims In …

$LLY $PFE $JNJ: Most of the profit in the health-care industry is going to drug companies — here’s why you should care

$LLY: FDA OK’s Lilly’s CYRAMZA for HCC

Latest News:

$AXJO $GOOGL $DXY: Asia markets set to open subdued with US-China trade negotiations said to hit a roadblock

$SPMO $SPX: There’s something strange going on with momentum stocks

$QD: Qudian’s Earnings Outlook

$QFIN: 360 Finance: A Unique ‘Tech-Giant Backed’ Fintech Opportunity

$PINS $TWTR $SNAP $FB: It was Pinterest’s full-year guidance that tripped the stock up

$MCD $KO: How to Set Up Your Children for Life

$JPM $AAPL $AMZN: JPMorgan Chase, Health Care And The ‘New’ Modern Corporation

$QD: Qudian Q1 2019 Earnings Preview

$IGT: International Game Technology PLC Q1 2019 Earnings Preview

$KMI $OPK: Notable Insider Buys This Past Week: Coty, Symantec and More

$TSN: African Swine Fever: An Opportunity For Tyson Foods